FLC
AXNX

Fifth Lane Capital’s Axonics, Inc. Common Stock AXNX Stock Holding History

Fifth Lane Capital’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-80,000
Closed -$5.52M – 181
2024
Q1 		$5.52M Buy
+80,000
New +$5.4M 4.76% 5

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Fifth Lane Capital's AXNX Position: Q2 2024 in Review

Fifth Lane Capital sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2024, closing a stake of 80,000 shares — an estimated $5.52M sold.

Fifth Lane Capital first reported a position in AXNX in Q1 2024 and held it in 1 quarter. The position peaked at $5.52M in Q1 2024. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2024.

  • Fifth Lane Capital reported no remaining Axonics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Fifth Lane Capital sold 80,000 Axonics, Inc. Common Stock shares in Q2 2024, an estimated $5.52M.
  • Fifth Lane Capital first reported a position in Axonics, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
  • Fifth Lane Capital's Axonics, Inc. Common Stock position peaked at $5.52M in Q1 2024.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2024.

Based on Fifth Lane Capital's 13F filing for Q2 2024, filed 14 Aug 2024.